Theravance Biopharma, Inc. (21) | Development Agreements (2)
- Development and Commercialization Agreement by and between Theravance Biopharma R&D, Inc. and Mylan Ireland Limited, dated January 30, 2015 (Filed With SEC on February 26, 2021)
- Amendment No. 1 to the Development and Commercialization Agreement by and between Theravance Biopharma Ireland Limited and Mylan Ireland Limited, dated June 12, 2019 (Filed With SEC on August 5, 2019)
